Eagle Health Investments LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001842545

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q1 2024 · 27 positions · Total reported value $538.22M · Top-10 concentration 69.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 54.8% · 4 new · 4 cut · 9 exited

Active Share (vs S&P 500): 99.7% · vs QQQ: 99.4% — share of the book that differs from index weights (higher = more active) · ranking

In its Q1 2024 13F filing, Eagle Health Investments LP disclosed 27 equity positions with a combined reported value of $538.22M. The filing implies a focused portfolio: its ten largest positions account for 69.1% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2024 were NTRA ($57.87M), ICLR ($50.25M), ILMN ($43.77M). By sector, the heaviest allocations are Health Care 88.4%, Industrials 7.7%. Versus the prior quarter, allocation shifted toward Other (+2.7pp) and away from Industrials (-2.7pp).

Versus the prior quarter, Eagle Health Investments LP opened 4 new positions, trimmed 4 and fully exited 9, a turnover rate of 54.8% of positions. The portfolio's overlap with the prior quarter was 75% of names.

The largest new positions opened in Q1 2024 were RARE ($13.99M), CRSP ($13.43M), EXAS ($8.36M).

Of the 9 positions fully exited versus the prior quarter, the largest were ADPT ($5.95M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • RARE ULTRAGENYX PHARMACEUTICAL IN · $13.99M
  • CRSP CRISPR THERAPEUTICS AG · $13.43M
  • EXAS EXACT SCIENCES CORP · $8.36M
  • TXG 10X GENOMICS INC · $5.07M
  • HOWL WEREWOLF THERAPEUTICS INC · $4.54M
  • VKTX VIKING THERAPEUTICS INC · $3.69M

Fully Exited (vs previous quarter)

  • ADPT ADAPTIVE BIOTECHNOLOGIES COR · prev qtr: $5.95M

Insider Transactions (Form 4)

Latest Eagle Health Investments LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Eagle Health Investments LP, based in Greenwich, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 27 positions worth $603.31M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: GREENWICH, CT, United States
  • SEC registration: 801-121917 (status: Approved), registered 2021-07-29
  • Regulatory AUM (Form ADV): $605.26M as of 2026-03-28
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 27 positions · $603.31M reported value (Q2 2026)
  • Top 10 holdings = 66.1% of reported value
  • Largest position: ARGX (ARGENX SE FUNSPONSORED ADR 1 ADR REPS 1 ORD SHS) at 11.8%
  • Average position size: $22.34M

Sector Tilt

  • Health Care 96.0%
  • Information Technology 2.5%
  • (classified holdings cover 98% of value)

Quarterly Activity

  • Q2 2026: 5 new, 9 added, 4 reduced, 5 exited
  • 9 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 88.4%
Other 3.8%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 632.71K $57.87M 10.75%
10.75%
Reduce
2 149.59K $50.25M 9.34%
9.34%
Reduce
3 318.75K $43.77M 8.13%
8.13%
Hold
4 179.50K $41.23M 7.66%
7.66%
Add
5 284.92K $39.52M 7.34%
7.34%
Reduce
6 84.59K $33.30M 6.19%
6.19%
Hold
7 121.89K $30.83M 5.73%
5.73%
Reduce
8 113.69K $28.39M 5.28%
5.28%
Reduce
9 122.20K $26.25M 4.88%
4.88%
Add
10 278.65K $20.60M 3.83%
3.83%
Reduce
11 337.22K $16.67M 3.10%
3.10%
Hold
12 730.21K $15.06M 2.80%
2.80%
Add
13 462.91K $14.75M 2.74%
2.74%
Add
14 35.59K $14.20M 2.64%
2.64%
Reduce
15 299.70K $13.99M 2.60%
2.60%
New
16 197.00K $13.43M 2.50%
2.50%
New
17 103.26K $13.37M 2.48%
2.48%
Reduce
18 579.77K $12.36M 2.30%
2.30%
Hold
19 330.83K $9.67M 1.80%
1.80%
Hold
20 121.00K $8.36M 1.55%
1.55%
New
21 2.17M $8.13M 1.51%
1.51%
Add
22 48.36K $7.23M 1.34%
1.34%
Reduce
23 135.06K $5.07M 0.94%
0.94%
New
24 700.00K $4.54M 0.84%
0.84%
New
25 45.00K $3.69M 0.69%
0.69%
New
26 46.30K $3.01M 0.56%
0.56%
Hold
27 43.20K $2.69M 0.50%
0.50%
Hold

FAQ

What did Eagle Health Investments LP buy in 2024-Q1?

In its 2024-Q1 13F filing, Eagle Health Investments LP reported 27 equity positions worth $538.22M in aggregate; its largest disclosed positions were NTRA ($57.87M), ICLR ($50.25M), ILMN ($43.77M).

How large is Eagle Health Investments LP's portfolio?

Eagle Health Investments LP reported $538.22M of long equity holdings across 27 positions as of 2024-Q1. Top-10 holdings account for 69.1% of reported value.

What is Eagle Health Investments LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/eagle-health-investments/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →